medigraphic.com
ISSN 1405-8871 (Print)

2017, Number 3

<< Back Next >>

Aten Fam 2017; 24 (3)

Urinary Symptoms in Patients with Prostatic Hyperplasia after an Educational Intervention

Figueroa-García J, Campos-Aragón L, Robles-Rodríguez A

Language: Spanish
References: 20
Page: 112-115
PDF size: 195.80 Kb.


ABSTRACT

Objective: to evaluate the urinary symptomatology in patients with prostatic hyperplasia before and after an educational intervention aimed to change dietary habits. Methods: quasi-experimental study, 136 family medicine patients of external consultation were included. The urinary symptoms were evaluated with the International Prostate Symptom Score (ipss) instrument, before and after an educational intervention aimed to change dietary habits. The t of Student test was used for the analysis of the results. Results: the general average to apply the ipss instrument before the educational intervention was 16.13, while the average after such intervention was 11.73, this decrease showed improvement in prostatic symptoms (p‹0.05). Conclusions: a decrease in the urinary symptomatology of patients with prostatic hyperplasia was observed after receiving educational intervention aimed to change dietary habits.


REFERENCES

  1. Nacach A, Figueroa-Torres CA, Méndez- Martini NP, López-Manjarrez J. Prostate biopsy and relation to prostate-specific antigen in patients diagnosed with benign prostatic hyperplasia. Revista Mexicana de Urología 2014;74(3):141-5.

  2. Maldonado-Alcaraz E, Moreno-Alcázar O, Neri-Pérez E. Guía de Práctica Clínica Diagnóstico y tratamiento de la hiperplasia prostática benigna [Internet]. México: Secretaria de Salud; 2009. Disponible en: http:// www.cenetec.salud.gob.mx/descargas/ gpc/CatalogoMaestro/176_GPC_HIPERPLASIA_ PROSTATICA/Gpc_hipertrofia_ prostatica.pdf

  3. Masumori, Naoya, et al. Natural history of benign prostatic hyperplasia. Journal of Men’s Health. 2011;8(Suppl 1);S19-S21.

  4. Anderson JB, Roehrborn CG, Schalken JA, Emberton M. The progression of benign prostatic hyperplasia. European Urology. 2011;39:390-9.

  5. Wei JT, Miner MM, Steers WD, et al. Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from Intervención educativa en pacientes con hiperplasia de próstata the observational bph registry. J Urol. 2011;186(3):971-6.

  6. Hassler E, Krakau I, Häggarth L, Norlén L, Ekman P. Questioning questions about symptoms of benign prostatic hyperplasia. Fam Pract. 2011;18:328-32.

  7. Djavan B, et al. Benign prostatic hyperplasia: current clinical practice. Prim Care. 2010;37(3):583-97.

  8. Keen CL. Diet and benign prostatic hyperplasia. Urology. 2011;54:284-90.

  9. Chyou PH, Nomura AM, Stemmermann GN, Hankin JH. A prospective study of alcohol, diet, and other lifestyle factors in relation to obstructive uropathy. Prostate. 2013;22:253-64.

  10. Badia X, García M, Dal RER. Ten language translation and harmonization of International Prostate Symptom Score: developing a multinational clinical trials. Eur Urol. 1997;31:129-40.

  11. Smith BD, Gupta U, Gupta BS. Caffeine and activation theory: effects on health and behavior. 1a ed. crc Press; 2010.

  12. Owen R. Fennema. Introducción a la ciencia de los alimentos. Vol. 1. 2a ed. Barcelona: Editorial Reverte; 2012. 115-26.

  13. Platz EA, Rimm EB, Kawachi I, Colditz GA, Stampfer MJ, Willett WC. Alcohol consumption, cigarette smoking, and risk of benign prostatic hyperplasia. Am J Epidemiol. 2010;149:106-15.

  14. Keen CL. Theobroma Caco: Biology, Chemistry, and Human Health. New York: John Wiley & Sons Inc.; 2011.

  15. Cunningham GR, Kadmon D. Medical treatment of benign prostatic hyperplasia. UpToDate [Internet]. 2007. Disponible en: https://www.uptodate.com/contents/medicaltreatment- of-benign-prostatic-hyperplasia.

  16. Gass R. Benign prostatic hyperplasia: the opposite effects of coffee intake. bju Int. 2012;90:649-54.

  17. Timothy J. Diagnosis of Bening prostatic hyperplasia. bmj. 2008;336:146-9.

  18. Kristal AR, Arnold KB, Schenk JM, et al. Race/ Ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia. J Urol. 2007;177:1395-400.

  19. Hirschi RM. Cultures and organizations. Intercultural cooperation and Health. New York: McGraw Hill; 2005.

  20. Jadue J, Holtedahl K, Stachenk S. Prevention in primary care. Recommendation for promoting good practice. Oxford Med Pub. 2011;254-260.




2020     |     www.medigraphic.com